Small Molecule Drug Discovery Market Forecast Signals New Revenue Opportunities Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Small Molecule Drug Discovery Market Growth Potential: How Will Market Size Change Through 2030?
The market for small molecule drug discovery has seen substantial expansion in recent years. Projections indicate a rise from $67.94 billion in 2025 to $75.56 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.2%. Factors driving this historical growth include heightened research and development spending by pharmaceutical firms, a growing incidence of chronic illnesses, progress made in molecular biology methods, an increased need for affordable treatment options, and the growing presence of contract research organizations (CROs).
The small molecule drug discovery market is projected to experience robust expansion in the coming years, reaching a value of $117.05 billion by 2030, with a compound annual growth rate (CAGR) of 11.6%. This forecasted growth is driven by factors such as the incorporation of artificial intelligence and machine learning into drug discovery processes, the broadening of precision medicine initiatives, heightened collaborative efforts between biotechnology and pharmaceutical companies, the deployment of automated high-throughput platforms, and an intensified emphasis on addressing rare and complex diseases. Notable trends shaping the future landscape include the widespread uptake of high-throughput screening, progress in combinatorial chemistry, the incorporation of nanotechnology into drug design, the advancement of personalized medicine, and improvements in target validation and lead optimization.
Download A Free Sample Report For Comprehensive Market Insights:
#Small Molecule Drug Discovery Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing prevalence of chronic illnesses is anticipated to propel the small molecule drug discovery market forward. Chronic diseases are defined as conditions lasting a year or longer that limit daily activities, require ongoing medical attention, or both. Small-molecule drugs are often employed to treat ailments such as HIV, cancer, infections, heart disease, and renal disease, and they are typically more cost-effective for patients managing long-term health issues. Consequently, the growing frequency of chronic conditions is expected to accelerate the small molecule drug discovery market. For example, a 2023 report from the National Institutes of Health (NIH), a U.S.-based biomedical research organization, indicates that the population of Americans aged 50 and over with at least one chronic illness is forecasted to hit 142.66 million by 2050. Moreover, the number of individuals experiencing multimorbidity is predicted to rise to 14.968 million by that same year. Thus, the escalating rate of chronic diseases is fueling expansion in the small molecule drug discovery market.
Small Molecule Drug Discovery Market Segment Analysis: What Are The Major Market Categories?
The small molecule drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others
Subsegments:
1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs
2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies
Small Molecule Drug Discovery Market Industry Trends: What Changes Are Reshaping Demand?
Leading firms within the small molecule drug discovery sector are actively forming partnerships as a strategy to boost their market revenues. These alliances typically encourage innovation by merging the specialized knowledge of various organizations. As an example, in November 2023, Evommune, a nonprofit entity based in the United States, joined forces with Accutar Biotechnology, an American biotechnology company, in a strategic collaboration centered on AI-driven drug discovery. The partnership specifically targets chronic inflammatory conditions and is designed to combine Accutar’s exclusive AI platform with Evommune’s deep expertise, aiming to identify new small molecule therapeutic candidates.
Small Molecule Drug Discovery Market Leading Companies Driving Competitive Growth
Major companies operating in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Allarity Therapeutics, Cyteir Therapeutics, BigHat Biosciences
Access The Complete Small Molecule Drug Discovery Market Report:
Small Molecule Drug Discovery Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the small molecule drug discovery market in 2025. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
